Arrowhead Pharmaceuticals Inc. (ARWR) Tops Q1 EPS by 10c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $71.86 --0%
Financial Fact:
TOTAL OTHER INCOME (EXPENSE): -79.26K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
TOTAL OTHER INCOME (EXPENSE): -79.26K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of $0.22, $0.10 better than the analyst estimate of $0.12. Revenue for the quarter came in at $264.03 million versus the consensus estimate of $227.61 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
- Daura Gold Upsizes Non-Brokered Private Placement to C$3 Million
- MaxLinear (MXL) Reiterated at Buy by Stifel on Diversified Supply Path
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
